Taher Doroudi

684 total citations
28 papers, 566 citations indexed

About

Taher Doroudi is a scholar working on Epidemiology, Hepatology and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Taher Doroudi has authored 28 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 7 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Taher Doroudi's work include Iron oxide chemistry and applications (7 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Taher Doroudi is often cited by papers focused on Iron oxide chemistry and applications (7 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Taher Doroudi collaborates with scholars based in Iran, Germany and United States. Taher Doroudi's co-authors include Pirhossein Kolivand, Mustafa Aghazadeh, Isa Karimzadeh, Mohammad Reza Ganjali, Parviz Norouzi, Seyed Moayed Alavian, Behzad Hajarizadeh, Simindokht Shirvani‐Arani, Hadi Kazemi and Seyed‐Mohammad Fereshtehnejad and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Taher Doroudi

27 papers receiving 513 citations

Peers

Taher Doroudi
Comparison fields: 5 of 107
  • Biomaterials 159
  • Materials Chemistry 146
  • Electrical and Electronic Engineering 136
  • Biomedical Engineering 136
  • Renewable Energy, Sustainability and the Environment 118
Replace Anurag Gautam with:
Anurag Gautam India
Tae–Un Kim South Korea
Haifeng Ma China
Runxuan Chu China
Xiaoxia Wu China
Masahiro Fukuda Japan
Fuqing Zhang China
Wei Ran China
Chunyang Zhang China
Anurag Gautam India View profile →
Citations per field, relative to Taher Doroudi
Taher Doroudi · 1×
Citations per year, relative to Taher Doroudi
Taher Doroudi · 1×

Countries citing papers authored by Taher Doroudi

Since Specialization
Citations

This map shows the geographic impact of Taher Doroudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taher Doroudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taher Doroudi more than expected).

Fields of papers citing papers by Taher Doroudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taher Doroudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taher Doroudi. The network helps show where Taher Doroudi may publish in the future.

Co-authorship network of co-authors of Taher Doroudi

This figure shows the co-authorship network connecting the top 25 collaborators of Taher Doroudi. A scholar is included among the top collaborators of Taher Doroudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taher Doroudi. Taher Doroudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 3
4 9
5 1
6 9
7 46
8 15
9 82
10 11
11 72
12 0
13
Anxiety and Depression in Patients with Amputated Limbs Suffering from Phantom Pain: A Comparative Study with Non-Phantom Chronic Pain
9
14
Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain.
13
15
Viral Hepatitis in Iranian Armed Forces: Prevalence of HBV and HCV in the Wounded-In-Action (WIA)
7
16 23
17
Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C
2
18
Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian
7
19
THE PREVALENCE OF HEPATITIS B AND C AMONG THALASSEMIA MAJOR PATIENTS IN GHAZVIN
5
20
THE EFFICACY OF BLOOD DONOR SCREENING IN REDUCING THE INCIDENCE OF HEPATITIS C VIRUS INFECTION AMONG THALASSEMIC PATIENTS IN IRAN
17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026